A citation-based method for searching scientific literature

M Rinaldi-Carmona, F Barth, M Héaulme, D Shire, B Calandra, C Congy, S Martinez, J Maruani, G Néliat, D Caput. FEBS Lett 1994
Times Cited: 1402







List of co-cited articles
1449 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
31

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
24

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
A C Howlett, F Barth, T I Bonner, G Cabral, P Casellas, W A Devane, C C Felder, M Herkenham, K Mackie, B R Martin,[...]. Pharmacol Rev 2002
23

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, N E Kaminski, A R Schatz, A Gopher, S Almog, B R Martin, D R Compton. Biochem Pharmacol 1995
23

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
R G Pertwee, A C Howlett, M E Abood, S P H Alexander, V Di Marzo, M R Elphick, P J Greasley, H S Hansen, G Kunos, K Mackie,[...]. Pharmacol Rev 2010
994
21

Determination and characterization of a cannabinoid receptor in rat brain.
W A Devane, F A Dysarz, M R Johnson, L S Melvin, A C Howlett. Mol Pharmacol 1988
20

Cannabinoid receptor localization in brain.
M Herkenham, A B Lynn, M D Little, M R Johnson, L S Melvin, B R de Costa, K C Rice. Proc Natl Acad Sci U S A 1990
19

Crystal Structure of the Human Cannabinoid Receptor CB1.
Tian Hua, Kiran Vemuri, Mengchen Pu, Lu Qu, Gye Won Han, Yiran Wu, Suwen Zhao, Wenqing Shui, Shanshan Li, Anisha Korde,[...]. Cell 2016
265
19

The orphan receptor GPR55 is a novel cannabinoid receptor.
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
966
15

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
T Sugiura, S Kondo, A Sukagawa, S Nakane, A Shinoda, K Itoh, A Yamashita, K Waku. Biochem Biophys Res Commun 1995
15

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.
R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wright. Br J Pharmacol 2015
406
15



SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
M Rinaldi-Carmona, F Barth, J Millan, J M Derocq, P Casellas, C Congy, D Oustric, M Sarran, M Bouaboula, B Calandra,[...]. J Pharmacol Exp Ther 1998
541
14

High-resolution crystal structure of the human CB1 cannabinoid receptor.
Zhenhua Shao, Jie Yin, Karen Chapman, Magdalena Grzemska, Lindsay Clark, Junmei Wang, Daniel M Rosenbaum. Nature 2016
205
13

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.
Robin Christensen, Pernelle Kruse Kristensen, Else Marie Bartels, Henning Bliddal, Arne Astrup. Lancet 2007
688
12

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
S Galiègue, S Mary, J Marchand, D Dussossoy, D Carrière, P Carayon, M Bouaboula, D Shire, G Le Fur, P Casellas. Eur J Biochem 1995
12

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice.
A Zimmer, A M Zimmer, A G Hohmann, M Herkenham, T I Bonner. Proc Natl Acad Sci U S A 1999
793
12

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.
C Ledent, O Valverde, G Cossu, F Petitet, J F Aubert, F Beslot, G A Böhme, A Imperato, T Pedrazzini, B P Roques,[...]. Science 1999
11

Allosteric modulation of the cannabinoid CB1 receptor.
Martin R Price, Gemma L Baillie, Adèle Thomas, Lesley A Stevenson, Morag Easson, Richard Goodwin, Adèle McLean, Lorraine McIntosh, Gillian Goodwin, Glenn Walker,[...]. Mol Pharmacol 2005
303
11


Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
M A Huestis, D A Gorelick, S J Heishman, K L Preston, R A Nelson, E T Moolchan, R A Frank. Arch Gen Psychiatry 2001
319
11


The endocannabinoid system as an emerging target of pharmacotherapy.
Pál Pacher, Sándor Bátkai, George Kunos. Pharmacol Rev 2006
11


Modulation of anxiety through blockade of anandamide hydrolysis.
Satish Kathuria, Silvana Gaetani, Darren Fegley, Fernando Valiño, Andrea Duranti, Andrea Tontini, Marco Mor, Giorgio Tarzia, Giovanna La Rana, Antonio Calignano,[...]. Nat Med 2003
10

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
A Thomas, G L Baillie, A M Phillips, R K Razdan, R A Ross, R G Pertwee. Br J Pharmacol 2007
403
10

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.
Jonathan Z Long, Weiwei Li, Lamont Booker, James J Burston, Steven G Kinsey, Joel E Schlosburg, Franciso J Pavón, Antonia M Serrano, Dana E Selley, Loren H Parsons,[...]. Nat Chem Biol 2009
658
10

Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.
Joseph Tam, Resat Cinar, Jie Liu, Grzegorz Godlewski, Daniel Wesley, Tony Jourdan, Gergő Szanda, Bani Mukhopadhyay, Lee Chedester, Jeih-San Liow,[...]. Cell Metab 2012
231
10

Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Marja D Van Sickle, Marnie Duncan, Philip J Kingsley, Abdeslam Mouihate, Paolo Urbani, Ken Mackie, Nephi Stella, Alexandros Makriyannis, Daniele Piomelli, Joseph S Davison,[...]. Science 2005
10

Crystal structures of agonist-bound human cannabinoid receptor CB1.
Tian Hua, Kiran Vemuri, Spyros P Nikas, Robert B Laprairie, Yiran Wu, Lu Qu, Mengchen Pu, Anisha Korde, Shan Jiang, Jo-Hao Ho,[...]. Nature 2017
212
10

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
T Bisogno, L Hanus, L De Petrocellis, S Tchilibon, D E Ponde, I Brandi, A S Moriello, J B Davis, R Mechoulam, V Di Marzo. Br J Pharmacol 2001
666
9

Agonistic properties of cannabidiol at 5-HT1a receptors.
Ethan B Russo, Andrea Burnett, Brian Hall, Keith K Parker. Neurochem Res 2005
418
9

Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
C C Felder, K E Joyce, E M Briley, J Mansouri, K Mackie, O Blond, Y Lai, A L Ma, R L Mitchell. Mol Pharmacol 1995
643
9

Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
John M McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G Pertwee. Br J Pharmacol 2015
264
9

The endocannabinoid system and the brain.
Raphael Mechoulam, Linda A Parker. Annu Rev Psychol 2013
494
9

Leptin-regulated endocannabinoids are involved in maintaining food intake.
V Di Marzo, S K Goparaju, L Wang, J Liu, S Bátkai, Z Járai, F Fezza, G I Miura, R D Palmiter, T Sugiura,[...]. Nature 2001
9

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.
Christine Ravinet Trillou, Michele Arnone, Claire Delgorge, Nadine Gonalons, Peter Keane, Jean-Pierre Maffrand, Philippe Soubrie. Am J Physiol Regul Integr Comp Physiol 2003
431
9


Early phytocannabinoid chemistry to endocannabinoids and beyond.
Raphael Mechoulam, Lumír O Hanuš, Roger Pertwee, Allyn C Howlett. Nat Rev Neurosci 2014
157
9

Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).
C J Hillard, S Manna, M J Greenberg, R DiCamelli, R A Ross, L A Stevenson, V Murphy, R G Pertwee, W B Campbell. J Pharmacol Exp Ther 1999
277
9

Endocannabinoid signaling at the periphery: 50 years after THC.
Mauro Maccarrone, Itai Bab, Tamás Bíró, Guy A Cabral, Sudhansu K Dey, Vincenzo Di Marzo, Justin C Konje, George Kunos, Raphael Mechoulam, Pal Pacher,[...]. Trends Pharmacol Sci 2015
334
9

Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
P J Little, D R Compton, M R Johnson, L S Melvin, B R Martin. J Pharmacol Exp Ther 1988
250
9

Endocannabinoid signaling and synaptic function.
Pablo E Castillo, Thomas J Younts, Andrés E Chávez, Yuki Hashimotodani. Neuron 2012
499
8


Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.
B R Martin, D R Compton, B F Thomas, W R Prescott, P J Little, R K Razdan, M R Johnson, L S Melvin, R Mechoulam, S J Ward. Pharmacol Biochem Behav 1991
329
8

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
Jean-Pierre Després, Alain Golay, Lars Sjöström. N Engl J Med 2005
997
8

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
Luciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, Marco Allarà, Tiziana Bisogno, Stefania Petrosino, Colin G Stott, Vincenzo Di Marzo. Br J Pharmacol 2011
419
8

PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats.
J G Horswill, U Bali, S Shaaban, J F Keily, P Jeevaratnam, A J Babbs, C Reynet, P Wong Kai In. Br J Pharmacol 2007
133
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.